Document and Entity Information
Document and Entity Information | Jan. 09, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 09, 2024 |
Entity File Number | 001-39743 |
Entity Registrant Name | KINNATE BIOPHARMA INC. |
Entity Central Index Key | 0001797768 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 82-4566526 |
Entity Address, Address Line One | 103 Montgomery Street, Suite 150 |
Entity Address, Address Line Two | The Presidio of San Francisco |
Entity Address, City or Town | San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94129 |
City Area Code | 858 |
Local Phone Number | 299-4699 |
Title of 12(b) Security | Common Stock, par value $0.0001 per share |
Trading Symbol | KNTE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |